Prothena Yönetim
Yönetim kriter kontrolleri 2/4
Prothena CEO'su Gene Kinney, Sep2016 tarihinde atandı, in görev süresi 8.17 yıldır. in toplam yıllık tazminatı $ 7.04M olup, şirket hissesi ve opsiyonları dahil olmak üzere 9% maaş ve 91% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.024% ine doğrudan sahiptir ve bu hisseler $ 213.03K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 7.7 yıl ve 5.1 yıldır.
Anahtar bilgiler
Gene Kinney
İcra Kurulu Başkanı
US$7.0m
Toplam tazminat
| CEO maaş yüzdesi | 9.0% |
| CEO görev süresi | 8.2yrs |
| CEO sahipliği | 0.02% |
| Yönetim ortalama görev süresi | 7.7yrs |
| Yönetim Kurulu ortalama görev süresi | 5.1yrs |
Son yönetim güncellemeleri
Recent updates
Prothena: Delays And Data Uncertainty Undermine Case For Investing (Downgrade)
Oct 18Prothena Corporation plc (NASDAQ:PRTA) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough
Oct 02
Unpleasant Surprises Could Be In Store For Prothena Corporation plc's (NASDAQ:PRTA) Shares
Jul 26Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth
Jun 19Prothena: Potential For Future Price Drop On Failure Risk Of Late-Stage Trials
Jun 07New Forecasts: Here's What Analysts Think The Future Holds For Prothena Corporation plc (NASDAQ:PRTA)
May 14Prothena: Alzheimer's Data Update In 2024 Could Move The Needle
Feb 23Investors Don't See Light At End Of Prothena Corporation plc's (NASDAQ:PRTA) Tunnel And Push Stock Down 33%
Feb 08Are Investors Undervaluing Prothena Corporation plc (NASDAQ:PRTA) By 32%?
Dec 20Prothena (NASDAQ:PRTA) Is In A Strong Position To Grow Its Business
Nov 24Prothena Corporation plc's (NASDAQ:PRTA) 29% Share Price Plunge Could Signal Some Risk
Oct 27Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth
Aug 25What You Need To Know About The Prothena Corporation plc (NASDAQ:PRTA) Analyst Downgrade Today
May 10We Think Prothena (NASDAQ:PRTA) Can Easily Afford To Drive Business Growth
Apr 23Time To Worry? Analysts Just Downgraded Their Prothena Corporation plc (NASDAQ:PRTA) Outlook
Mar 01We're Not Very Worried About Prothena's (NASDAQ:PRTA) Cash Burn Rate
Dec 28Prothena: Paying A Premium To Cover All The Alzheimer's Bases
Sep 29Prothena GAAP EPS of -$0.88 misses by $0.31
Aug 08Bearish: Analysts Just Cut Their Prothena Corporation plc (NASDAQ:PRTA) Revenue and EPS estimates
May 08CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$51m |
| Mar 31 2024 | n/a | n/a | -US$172m |
| Dec 31 2023 | US$7m | US$631k | -US$147m |
| Sep 30 2023 | n/a | n/a | -US$73m |
| Jun 30 2023 | n/a | n/a | -US$141m |
| Mar 31 2023 | n/a | n/a | -US$128m |
| Dec 31 2022 | US$7m | US$601k | -US$117m |
| Sep 30 2022 | n/a | n/a | -US$156m |
| Jun 30 2022 | n/a | n/a | -US$1m |
| Mar 31 2022 | n/a | n/a | US$67m |
| Dec 31 2021 | US$5m | US$573k | US$67m |
| Sep 30 2021 | n/a | n/a | US$69m |
| Jun 30 2021 | n/a | n/a | -US$70m |
| Mar 31 2021 | n/a | n/a | -US$124m |
| Dec 31 2020 | US$3m | US$554k | -US$111m |
| Sep 30 2020 | n/a | n/a | -US$102m |
| Jun 30 2020 | n/a | n/a | -US$91m |
| Mar 31 2020 | n/a | n/a | -US$80m |
| Dec 31 2019 | US$3m | US$538k | -US$78m |
| Sep 30 2019 | n/a | n/a | -US$79m |
| Jun 30 2019 | n/a | n/a | -US$84m |
| Mar 31 2019 | n/a | n/a | -US$128m |
| Dec 31 2018 | US$11m | US$525k | -US$156m |
| Sep 30 2018 | n/a | n/a | -US$181m |
| Jun 30 2018 | n/a | n/a | -US$209m |
| Mar 31 2018 | n/a | n/a | -US$167m |
| Dec 31 2017 | US$5m | US$521k | -US$153m |
Tazminat ve Piyasa: Gene 'nin toplam tazminatı ($USD 7.04M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 3.23M ).
Tazminat ve Kazançlar: Gene şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.
CEO
Gene Kinney (55 yo)
8.2yrs
Görev süresi
US$7,043,826
Tazminat
Dr. Gene G. Kinney, Ph D., has been the Chief Executive Officer and President of Prothena Corporation plc since September 26, 2016 and October 3, 2016 respectively and served as its Chief Operating Officer...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| President | 8.2yrs | US$7.04m | 0.024% $ 213.0k | |
| CFO & Chief Strategy Officer | 11.7yrs | US$2.70m | 0.0060% $ 53.3k | |
| Chief Operating Officer | 3.1yrs | US$2.63m | 0% $ 0 | |
| Chief Regulatory Officer | 7.9yrs | US$2.57m | 0% $ 0 | |
| Chief Accounting Officer & Controller | 11.5yrs | Veri yok | Veri yok | |
| Chief Scientific Officer | 7.4yrs | US$3.34m | Veri yok | |
| Vice President of Investor Relations | no data | Veri yok | Veri yok | |
| Chief Legal Officer | no data | US$1.18m | Veri yok | |
| Chief People Officer | less than a year | Veri yok | Veri yok | |
| Chief Development Officer | less than a year | Veri yok | Veri yok | |
| Company Secretary | no data | Veri yok | Veri yok |
7.7yrs
Ortalama Görev Süresi
55yo
Ortalama Yaş
Deneyimli Yönetim: PRTA 'un yönetim ekibi deneyimli ve deneyimlidir ( 7.7 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| President | 8.2yrs | US$7.04m | 0.024% $ 213.0k | |
| Independent Director | 2.3yrs | US$896.63k | 0% $ 0 | |
| Independent Director | 11.9yrs | US$912.48k | 0.0023% $ 20.3k | |
| Independent Chairman | less than a year | Veri yok | Veri yok | |
| Independent Chair Emeritus | less than a year | US$923.48k | 0.00045% $ 4.0k | |
| Independent Director | 11.9yrs | US$917.26k | 0% $ 0 | |
| Independent Director | 11.3yrs | US$901.73k | 0.0078% $ 70.0k | |
| Independent Director | 5.3yrs | US$908.48k | 0% $ 0 | |
| Independent Director | 4.9yrs | Veri yok | Veri yok | |
| Independent Director | 1.5yrs | US$1.70m | Veri yok |
5.1yrs
Ortalama Görev Süresi
62yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: PRTA 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.1 yıldır).